194 related articles for article (PubMed ID: 25367165)
21. Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
McEvoy JP; Citrome L; Hernandez D; Cucchiaro J; Hsu J; Pikalov A; Loebel A
J Clin Psychiatry; 2013 Feb; 74(2):170-9. PubMed ID: 23473350
[TBL] [Abstract][Full Text] [Related]
22. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
[TBL] [Abstract][Full Text] [Related]
23. A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder.
Kim CY; Chung S; Lee JN; Kwon JS; Kim DH; Kim CE; Jeong B; Jeon YW; Lee MS; Jun TY; Jung HY
Int Clin Psychopharmacol; 2009 Jul; 24(4):181-8. PubMed ID: 19451828
[TBL] [Abstract][Full Text] [Related]
24. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
25. New atypical antipsychotics for schizophrenia: iloperidone.
Caccia S; Pasina L; Nobili A
Drug Des Devel Ther; 2010 Feb; 4():33-48. PubMed ID: 20368905
[TBL] [Abstract][Full Text] [Related]
26. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
27. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
28. Strategies for transitioning therapy to aripiprazole from other antipsychotics in schizophrenia.
Wisniewski CS; Robert S
Ann Pharmacother; 2012; 46(7-8):1097-104. PubMed ID: 22811346
[TBL] [Abstract][Full Text] [Related]
29. Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.
Volpi S; Potkin SG; Malhotra AK; Licamele L; Lavedan C
J Clin Psychiatry; 2009 Jun; 70(6):801-9. PubMed ID: 19573479
[TBL] [Abstract][Full Text] [Related]
30. A prospective, multicentre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with Aripiprazole in Europe (EU-BETA).
Wolf J; Janssen F; Lublin H; Salokangas RK; Allain H; Smeraldi E; Bernardo M; Millar H; Pans M; Adelbrecht C; Laughton J; Werner C; Maier W
Curr Med Res Opin; 2007 Oct; 23(10):2313-23. PubMed ID: 17706003
[TBL] [Abstract][Full Text] [Related]
31. Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.
Kim SW; Chung YC; Lee YH; Lee JH; Kim SY; Bae KY; Kim JM; Shin IS; Yoon JS
Int Clin Psychopharmacol; 2012 Sep; 27(5):267-74. PubMed ID: 22809972
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness and tolerability of switching to aripiprazole from risperidone in subjects with autism spectrum disorders: a prospective open-label study.
Ishitobi M; Kosaka H; Takahashi T; Yatuga C; Asano M; Tanaka Y; Ueno K; Okazaki R; Omori M; Hiratani M; Tomoda A; Wada Y
Clin Neuropharmacol; 2013; 36(5):151-6. PubMed ID: 24045605
[TBL] [Abstract][Full Text] [Related]
33. Predictors of early worsening after switch to aripiprazole: a randomized, controlled, open-label study.
Pae CU; Chiesa A; Mandelli L; Patkar AA; Gibiino S; Serretti A
Clin Drug Investig; 2010; 30(3):187-93. PubMed ID: 20155991
[TBL] [Abstract][Full Text] [Related]
34. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
[TBL] [Abstract][Full Text] [Related]
35. A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering.
Takeuchi H; Suzuki T; Uchida H; Nakajima S; Nomura K; Kikuchi T; Manki H; Watanabe K; Kashima H
J Clin Psychopharmacol; 2008 Oct; 28(5):540-3. PubMed ID: 18794650
[TBL] [Abstract][Full Text] [Related]
36. Iloperidone for the treatment of schizophrenia.
Bishop JR; Bishop DL
Drugs Today (Barc); 2010 Aug; 46(8):567-79. PubMed ID: 20830317
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
[TBL] [Abstract][Full Text] [Related]
38. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder.
Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR
Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772
[TBL] [Abstract][Full Text] [Related]
39. Antipsychotic medication in adolescents suffering from schizophrenia: a meta-analysis of randomized controlled trials.
Ardizzone I; Nardecchia F; Marconi A; Carratelli TI; Ferrara M
Psychopharmacol Bull; 2010; 43(2):45-66. PubMed ID: 21052042
[TBL] [Abstract][Full Text] [Related]
40. Long-term effectiveness of flexibly dosed paliperidone extended-release: comparison among patients with schizophrenia switching from risperidone and other antipsychotic agents.
Kim EY; Chang SM; Shim JC; Joo EJ; Kim JJ; Kim YS; Ahn YM
Curr Med Res Opin; 2013 Oct; 29(10):1231-40. PubMed ID: 23777311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
